This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Apr 20;376(16):1596.

doi: 10.1056/NEJMc1702531.

Bezlotoxumab and Recurrent Clostridium difficile Infection

John G Bartlett¹

Affiliations

PMID: 28423300
DOI: 10.1056/NEJMc1702531

Free article

Comment

Bezlotoxumab and Recurrent Clostridium difficile Infection

John G Bartlett. N Engl J Med. 2017.

Free article

. 2017 Apr 20;376(16):1596.

doi: 10.1056/NEJMc1702531.

Author

John G Bartlett¹

Affiliation

¹ Johns Hopkins University School of Medicine, Baltimore, MD.

PMID: 28423300
DOI: 10.1056/NEJMc1702531

No abstract available

PubMed Disclaimer

Comment on

Bezlotoxumab and Recurrent Clostridium difficile Infection.
Sommer H, Timsit JF, Wolkewitz M; COMBACTE-NET Consortium. Sommer H, et al. N Engl J Med. 2017 Apr 20;376(16):1594. doi: 10.1056/NEJMc1702531. N Engl J Med. 2017. PMID: 28423299 No abstract available.
Bezlotoxumab and Recurrent Clostridium difficile Infection.
Maw A, Shen N, Francis P. Maw A, et al. N Engl J Med. 2017 Apr 20;376(16):1593-4. doi: 10.1056/NEJMc1702531. N Engl J Med. 2017. PMID: 28425276 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations